This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Chronic obstructive pulmonary disease (COPD) and b...
  • /
  • Evolving Concepts in Chronic Obstructive Pulmonary...

Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers.

Read time: 1 mins
Published:1st Oct 2019
Author: Cazzola M, Puxeddu E, Ora J, Rogliani P.
Availability: Pay for access, or by subscription
Ref.:Mol Diagn Ther. 2019;23(5):603-614.

In recent years, there has been a great deal of interest in the identification and validation of blood-based biomarkers for clinical use in chronic obstructive pulmonary disease (COPD). We now have panels of blood biomarkers that potentially hold great promise as they show statistically significant associations with COPD, but biomarkers for the diagnosis of COPD remain elusive.

In fact, they are yet to demonstrate sufficient accuracy to be accepted in clinical use, and many are not specific to COPD but more related to inflammation (e.g. interleukin-6) or associated with other chronic diseases such as diabetes (e.g. soluble receptor for advanced glycation endproducts [sRAGE]). Although no single blood-based biomarker has demonstrated clinical utility for either the diagnosis or progression of COPD, it has been suggested that combinations of individual markers may provide important diagnostic or prognostic information; however, the interpretation of COPD biomarker results still requires thought and many questions remain unanswered.


Read abstract on library site

Access full article